<div id="readability-page-1">01:51 PM EST, 01/22/2026 (MT Newswires) -- Health care stocks advanced Thursday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each adding 0.3%.The iShares Biotechnology ETF (IBB) rose 1.5%.In corporate news, Moderna ( MRNA ) isn't planning to invest in new late-stage vaccine trials due to growing opposition to vaccines from US officials, Bloomberg reported, citing Chief Executive Stephane Bancel. &#34;You cannot make a return on investment if you don't have access to the US market,&#34; Bancel said in an interview with Bloomberg TV at the World Economic Forum in Davos, Switzerland. Moderna ( MRNA ) shares were up 6.7%.Abbott Laboratories ( ABT ) issued a Q1 earnings outlook below market estimates on Thursday, and the healthcare company's revenue in the previous three-month period trailed expectations. Its shares dropped past 9%.60 Degrees Pharmaceuticals ( SXTP ) shares surged 151% after it said Thursday it is launching a partnership with Runway Health to boost access to Arakoda for the prevention of malaria. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

MRNA

SXTP

Health care stocks rose in afternoon trading, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF increasing by 0.3%. The iShares Biotechnology ETF gained 1.5%. Moderna's shares rose 6.7% despite the company not planning new vaccine trials due to US opposition. Abbott Laboratories' shares fell over 9% after issuing a Q1 earnings outlook below estimates. In contrast, 60 Degrees Pharmaceuticals' shares surged 151% following a partnership announcement with Runway Health for malaria prevention.

Sector Update: Health Care Stocks Rise in Afternoon Trading